Medtronic presents positive data on TAVR, TMVR devices
Medtronic (NYSE:MDT) announced data from multiple trials supporting its transcatheter heart valve replacement devices.
United States Firas Zahr Medtronic Corevalve Nina Goodheart Corevalve Evolut Program Transcatheter Cardiovascular Therapeutics
Source: massdevice.com